Research Papers

25 of 167 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Forkhead box P3 gene polymorphisms predispose to type 2 diabetes and diabetic nephropathy in the Han Chinese population…
Wang X; Liu Z; Zhang S; Yang Y; Wu X; Liu X.
Hereditas (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Identification of the prognostic value of Th1/Th2 ratio and a novel prognostic signature in basal-like breast cancer.
Xiao Y; Huang Y; Jiang J; Chen Y; Wei C.
Hereditas (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Upregulation of CENPM is associated with poor clinical outcome and suppression of immune profile in clear cell renal ce…
Zhang ZC; Liu YF; Xi P; Nie YC; Sun T; Gong BB.
Hereditas (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Stages of preadipocyte differentiation: biomarkers and pathways for extracellular structural remodeling.
Hu Z; Liu Y; Yao Z; Chen L; Wang G; Liu X; Tian Y; Cao G.
Hereditas (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Variations in the TAS2R38 gene among college students in Hubei.
Wang X; Wang L; Xia M; Teng F; Chen X; Huang R; Zhou J; Xiao J; Zhai L.
Hereditas (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Mechanisms of Cynarine for treatment of non-alcoholic fatty liver disease based on the integration of network pharmacol…
Sun CY; Yang LL; Zhao P; Yan PZ; Li J; Zhao DS.
Hereditas (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Bioinformatics analysis of diagnostic biomarkers for Alzheimer's disease in peripheral blood based on sex differences a…
Ji W; An K; Wang C; Wang S.
Hereditas (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
Identification of tubulointerstitial genes and ceRNA networks involved in diabetic nephropathy via integrated bioinform…
Cao H; Rao X; Jia J; Yan T; Li D.
Hereditas (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
An artificial neural network model based on autophagy-related genes in childhood systemic lupus erythematosus.
Wu J; Yang W; Li H.
Hereditas (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
A novel molecular subtypes and risk model based on inflammatory response-related lncrnas for bladder cancer.
Tang F; Zhang J; Lu Z; Liao H; Hu C; Mai Y; Lai Y; Lu Z; Tang Z; Li Z; He Z.
Hereditas (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Susceptibility genes of hyperuricemia and gout.
Nian YL; You CG.
Hereditas (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Mutation update of SERPING1 related to hereditary angioedema in the Chinese population.
Wang X; Lei S; Xu Y; Liu S; Zhi Y.
Hereditas (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
ARG1 as a promising biomarker for sepsis diagnosis and prognosis: evidence from WGCNA and PPI network.
Zhang JX; Xu WH; Xing XH; Chen LL; Zhao QJ; Wang Y.
Hereditas (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Insights into AIM-InDel diversities in Yunnan Miao and Hani ethnic groups of China for forensic and population genetic …
Cui W; Nie S; Fang Y; Chen M; Zhao M; Lan Q; Shen C; Zhu B.
Hereditas (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
SKA3 is a prognostic biomarker and associated with immune infiltration in bladder cancer.
Wang C; Liu S; Zhang X; Wang Y; Guan P; Bu F; Wang H; Wang D; Fan Y; Hou S; Qiu Z.
Hereditas (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
N6-methyladenosine-related lncRNAs is a potential marker for predicting prognosis and immunotherapy in ovarian cancer.
Nie X; Tan J.
Hereditas (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Identification of a chromatin regulator signature and potential candidate drugs for bladder cancer.
Zhu K; Liu X; Deng W; Wang G; Fu B.
Hereditas (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Protein content and HvNAM alleles in Nordic barley (Hordeum vulgare) during a century of breeding.
Hagenblad J; Vanhala T; Madhavan S; Leino MW.
Hereditas (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
Identification and development of the novel 7-genes diagnostic signature by integrating multi cohorts based on osteoart…
Han Y; Wu J; Gong Z; Zhou Y; Li H; Chen Y; Qian Q.
Hereditas (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Identification of novel mutations among Iranian NPC1 patients: a bioinformatics approach to predict pathogenic mutation…
Abtahi R; Karimzadeh P; Aryani O; Akbarzadeh D; Salehpour S; Rezayi A; Tonekaboni SH; Emameh RZ; Houshmand M.
Hereditas (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
SLC3A2 inhibits ferroptosis in laryngeal carcinoma via mTOR pathway.
Wu F; Xiong G; Chen Z; Lei C; Liu Q; Bai Y.
Hereditas (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Single-nucleotide polymorphisms and activities of indoleamine 2,3-dioxygenase isoforms, IDO1 and IDO2, in tuberculosis …
Cao T; Dai G; Chu H; Kong C; Duan H; Tian N; Sun Z.
Hereditas (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Cell-free DNA from plasma as a promising alternative for detection of gene mutations in patients with Maffucci syndrome.
Sun Y; Fan X; Rao Y; Wang Z; Wang D; Yang X; Zheng L; Wen M; Cai R; Su L.
Hereditas (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Identification of a five-miRNA signature as a novel potential prognostic biomarker in patients with nasopharyngeal carc…
Tu B; Ye L; Cao Q; Gong S; Jiang M; Li H.
Hereditas (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
Complex vascular anomalies and tissue overgrowth of limbs associated with increased skin temperature and peripheral ven…
Su LX; Sun Y; Wang Z; Wang D; Yang X; Zheng L; Wen M; Fan X; Cai R.
Hereditas (Unknown)
Published: 2022
3/6 Transparent
Funding Declared